IL9 and asthma: Interestingly glucocorticoids, potent immune-suppressive agents that reduce cytokine expression by inhibiting transcription factors such as Activation Protein (AP)-1 and NF-κB, have been observed to reduce IL-9 expression in asthma patients [40,105].